#childhood cancer

A CAR T-Cell Therapy for Multiple Childhood Cancers?

An expert hopes to use gathered data to establish guidelines for how best to sample lymph nodes during surgery for pediatric kidney cancer.

CU Cancer Center member Adam Green, MD, covers the symptoms, diagnosis, and treatment of pediatric brain tumors.

Research reinforces recommendations from the American Cancer Society and American Academy of Pediatrics to start HPV vaccines at a young age

Until recently, much of the research on liquid biopsies focused on their use in adults with cancer.

University of Colorado’s Adam Green, MD, aims to use research findings to help address disparities in childhood cancers.

National Cancer Institute director Monica Bertagnolli, MD, on launching Cancer Moonshot programs and ending cancer as we know it.

To put a spotlight on the types of cancer that largely affect children and survivorship issues.

Every year, 350 children in the United States are diagnosed with rhabdomyosarcoma.

Combination therapy using Taflinar and Mekinst led to improved response for pediatric patients with low-grade gliomas

Latino children and those with public insurance had poorer survival even if they received the same treatment in clinical trials.

The collaboration will address disparities in cancer care in high-income and lower-income countries.

Thirty-five years post-cancer diagnosis, one in seven survivors developed new cancer and one in 16 survivors died from new cancer.

Minimal residual disease status may not be as strong a predictor of relapse in Latino children.

Pediatric patients were matched to therapies targeting specific mutations found in their cancers.

Research led by Adam Green, MD, shows the five-year survival rates for children ages 0 to 3 months is half that of children ages 1 to 19.

Women with a history of childhood cancer have a “really good chance of getting pregnant” and staying healthy. But know the risks.